In vivo analysis of biocompatibility and vascularization of the synthetic bone grafting substitute NanoBone®

Journal of Biomedical Materials Research - Part A

Volumn 91, Issue 2, 2009, Pages 557-566

  Abshagen, K ^a   Schrodi, I ^a   Gerber, T ^a   Vollmar, B ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Angiogenesis; Biocompatibility; Dorsal skinfold chamber; Hydroxyapatite; NanoBone

Indexed keywords

ANGIOGENESIS; BONE DEFECT; BONE GRAFTING MATERIALS; BONE SUBSTITUTES; CANCELLOUS BONE; DORSAL SKINFOLD CHAMBER; DORSAL SKINFOLD CHAMBERS; FIBROUS TISSUE; FOREIGN BODY GIANT CELLS; HOST TISSUES; IN-VIVO; IN-VIVO ANALYSIS; INFLAMMATORY RESPONSE; MACROSTRUCTURES; MICROVASCULAR; NANOBONE; NANOCRYSTALLINES; NEOVASCULARIZATION; SYNTHETIC BONE; VASCULARIZATION;

APATITE; BIOLOGICAL MATERIALS; BONE; CELL MEMBRANES; DOSIMETRY; ENDOTHELIAL CELLS; GRAFTING (CHEMICAL); GRANULATION; HYDROXYAPATITE;

BIOCOMPATIBILITY;

HYDROXYAPATITE; NANOCRYSTAL; NANOMATERIAL; SILICA GEL;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BONE BLOOD FLOW; BONE GRAFT; BONE GROWTH; BONE PLATE; BONE PROSTHESIS; CANCELLOUS BONE; CELL INTERACTION; CONTROLLED STUDY; ENDOTHELIUM CELL; GIANT CELL; HEMODYNAMICS; HISTOLOGY; INFLAMMATION; LEUKOCYTE; MALE; MICROVASCULARIZATION; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN;

ANIMALS; BONE SUBSTITUTES; DRUG COMBINATIONS; DURAPATITE; HEMODYNAMICS; MALE; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; SILICON DIOXIDE;

EID: 70349446443     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32237     Document Type: Article

References (27)

1. Nomi M, Atala A, Coppi PD, Soker S. Principals of neovascularization for tissue engineering. Mol Aspects Med 2002;23: 463-483.
2. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000;6:389-395.
3. Giannoudis PV, Dinopoulos H, Tsiridis E. Bone substitutes: An update. Injury 2005;36:20-27.
4. Seiler JG III, Johnson J. Iliac crest autogenous bone grafting: Donor site complications. J South Orthop Assoc 2000;9:91-97.
5. Betz RR. Limitations of autograft and allograft: New synthetic solutions. Orthopedics 2002;25:561-570.
6. Moore WR, Graves SE, Bain GI. Synthetic bone graft substitutes. ANZ J Surg 2001;71:354-361.
7. Rumpel E, Wolf E, Kauschke E, Bienengraber V, Bayerlein T, Gedrange T, Proff P. The biodegradation of hydroxyapatite bone graft substitutes in vivo. Folia Morphol (Warsz) 2006; 65:43-48.
8. Gerike W, Bienengräber V, Henkel KO, Bayerlein T, Proff P, Gedrange T, Gerber T. The manufacture of synthetic nonsintered and degradable bone grafting substitutes. Folia Morphol (Warsz) 2006;65:54-55.
9. Menger MD, Laschke MW, Vollmar B. Viewing the microcirculation through the window: Some twenty years experience with the hamster dorsal skinfold chamber. Eur Surg Res 2002;34:83-91. (Pubitemid 34195702)
10. Bayerlein T, Proff P, Fanghanel J, Kauschke E, Rumpel E, Gerike W, Bienengraber V, Gedrange T. Wound management after the application of bone grafting substitutes in the orofacial region. Folia Morphol (Warsz) 2006;65:89-91.
11. Endrich B, Asaishi K, Gotz A, Messmer K. Technical report - A new chamber technique for microvascular studies in unanesthetized hamsters. Res Exp Med (Berl) 1980;177:125-134. (Pubitemid 11238699)
12. Hoffmann JN, Vollmar B, Laschke MW, Inthorn D, Schildberg FW, Menger MD. Hydroxyethyl starch (130 kD), but not crystalloid volume support, improves microcirculation during normotensive endotoxemia. Anesthesiology 2002;97:460-470. (Pubitemid 34847761)
13. Klyscz T, Junger M, Jung F, Zeintl H. Cap image - A new kind of computer-assisted video image analysis system for dynamic capillary microscopy. Biomed Tech (Berl) 1997;42: 168-175.
14. Baker M, Wayland H. On-line volume flow rate and velocity profile measurement for blood in microvessels. Microvasc Res 1974;7:131-143.
15. Soker S, Machado M, Atala A. Systems for therapeutic angiogenesis in tissue engineering. World J Urol 2000;18:10-18.
16. Laschke MW, Harder Y, Amon M, Martin I, Farhadi J, Ring A, Torio-Padron N, Schramm R, Rucker M, Junker D, Haufel JM, Carvalho C, Heberer M, Germann G, Vollmar B, Menger MD. Angiogenesis in tissue engineering: Breathing life into constructed tissue substitutes. Tissue Eng 2006;12:2093-2104. (Pubitemid 44734969)
17. Cypher TJ, Grossman JP. Biological principles of bone graft healing. J Foot Ankle Surg 1996;35:413-417.
18. Yamauchi J, Wolf B, Vollmar B, Menger MD. In vivo analysis of the origin of capillary sprout formation in angiogenesis of freely transplanted islets of Langerhans. Adv Exp Med Biol 1998;454:355-360.
19. Sommer B, Felix R, Sprecher C, Leunig M, Ganz R, Hofstetter W. Wear particles and surface topographies are modulators of osteoclastogenesis in vitro. J Biomed Mater Res A 2005;72: 67-76. (Pubitemid 39628334)
20. Laschke MW, Witt K, Pohlemann T, Menger MD. Injectable nanocrystalline hydroxyapatite paste for bone substitution: in vivo analysis of biocompatibility and vascularization. J Biomed Mater Res B Appl Biomater 2007;82:494-505.
21. Ogose A, Kondo N, Umezu H, Hotta T, Kawashima H, Tokunaga K, Ito T, Kudo N, Hoshino M, Gu W, Endo N. Histological assessment in grafts of highly purified beta-tricalcium phosphate (OSferion) in human bones. Biomaterials 2006;27: 1542-1549. (Pubitemid 41739579)
22. Takeshita N, Akagi T, Yamasaki M, Ozeki T, Nojima T, Hiramatsu Y, Nagai N. Osteoclastic features of multinucleated giant cells responding to synthetic hydroxyapatite implanted in rat jaw bone. J Electron Microsc (Tokyo) 1992;41:141-146.
23. Franz-Odendaal TA, Hall BK, Witten PE. Buried alive: How osteoblasts become osteocytes. Dev Dyn 2006;235:176-190.
24. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249-257.
25. Rubanyi GM, Polokoff MA. Endothelins: Molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 1994;46:325-415.
26. Posner AS. Crystal chemistry of bone mineral. Physiol Rev 1969;49:760-792.
27. Du C, Cui FZ, Feng QL, Zhu XD, de Groot K. Tissue response to nanohydroxyapatite/collagen composite implants in marrow cavity. J Biomed Mater Res 1998;42:540-548. (Pubitemid 28503758)